Why Shares of This Top Coronavirus Vaccine Hopeful Popped in September
Shares of biotech company Vaxart (NASDAQ: VXRT) rose 12.1% in September, according to data provided by S&P Global Market Intelligence. Year to date, on the other hand, the start-up's shares have soared nearly 2,000%, an eye-popping number reflecting investors' interest in potential coronavirus vaccines. The big news for Vaxart came on Sept. 14, when the Food and Drug Administration granted Investigational New Drug clearance to the company's oral coronavirus vaccine candidate.
